INCYTE CORPORATION Operating Lease, Liability, Current
INCYTE CORPORATION (INCY) had Operating Lease, Liability, Current of $5.60 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-04-28
- 2026-03-31: Operating Lease, Liability, Current $5.60M.
- 2025-12-31: Operating Lease, Liability, Current $5.70M.
- 2025-09-30: Operating Lease, Liability, Current $5.89M.
- 2025-06-30: Operating Lease, Liability, Current $6.17M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-03-31 | $5.60M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $5.70M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $5.89M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $6.17M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $6.00M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $5.58M 10-K · filed 2026-02-10 |
| 2024-09-30 | $4.35M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $4.93M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $4.78M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $5.69M 10-K · filed 2025-02-10 |
| 2023-09-30 | $6.18M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $7.08M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $7.39M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $8.20M 10-K · filed 2024-02-13 |
| 2022-09-30 | $8.49M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $9.37M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $9.90M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $10.55M 10-K · filed 2023-02-07 |
| 2021-09-30 | $9.85M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $10.99M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $11.66M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $12.67M 10-K · filed 2022-02-08 |
| 2020-09-30 | $10.71M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.06M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $9.02M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $9.34M 10-K · filed 2021-02-09 |
| 2019-09-30 | $10.37M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $10.83M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $10.24M 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |